This was the BlackBerry era of fashion, extravagance and scandals … but no one’s told the story,” Filipa Fino told Page Six.

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...

One of OpenShot’s strongest technical advantages is its format support, thanks to its use of the FFmpeg library. You can ...

A month has gone by since the last earnings report for Editas Medicine (EDIT). Shares have lost about 8.3% in that time frame, underperforming the S&P 500. But investors have to be wondering, will the ...

Every day, Minnesotans drive across bridges, drink clean water, and rely on infrastructure that few ever think twice about. Yet the professionals who design, maintain and improve those systems begin ...

Holiday artwork by Irving ISD students is on display in the Main Gallery of the Irving Arts Center. A letter writer praises arts educators. 1 Arts educators — American Education Week (Nov. 17–21) ...

The BBC has issued an apology to President Trump over editing of a speech he gave on Jan. 6, 2021, that aired in its documentary "Trump: A Second Chance." Mr. Trump had threatened to sue the British ...

As cooler weather settles in, many Hoosiers are preparing their homes for the winter season – checking furnaces, sealing windows and thinking ahead about ways to manage energy use efficiently. Duke ...

Paramount Skydance on Monday confirmed that it will acquire The Free Press in a $150 million deal — and elevate its founder, Bari Weiss, to the top role as editor in chief of CBS News. Weiss, 41, will ...

Reforming the federal 340B Drug Pricing Program is a fast and efficient way to reduce drug costs and protect patients. These days, some 340B hospitals are taking advantage of low-income and uninsured ...

Editas Medicine Inc. (NASDAQ:EDIT) is one of the best performing penny stocks to buy now. On September 5, HC Wainwright reiterated a “Buy” rating on the stock and a $5 price target. The positive ...